StockData
Radiopharm Theranostics Ltd logo

Radiopharm Theranostics Ltd (RADX) stock

RADXNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as RDPTF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 30, 2026Score 6/30
$0.67−0.10 (-12.58%)

Close on Nov 17, 2026Market cap $7.93MP/E –Yield –

Radiopharm Theranostics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2026 it was -$56.78M.

Annual operating income

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$56.78M–
FY2025Jun 30, 2025-$38.17M–
FY2024Jun 30, 2024-$47.21M–
FY2023Jun 30, 2023-$34.49M–

More Radiopharm Theranostics figures

See a number that looks wrong?